Abiraterone shows good results in advanced prostate cancer. PDF Print
SFgate: The hormone treatment, Johnson & Johnson's Zytiga, when added to a standard steroid therapy doubled the time it takes for the disease to progress in patients treated with the standard therapy alone, said the lead researcher, Dr. Charles Ryan, associate professor of clinical medicine at the UCSF Helen Diller Family Comprehensive Cancer Center.

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.